Company: HCWB
Filing Date: 2025-04-07
Form Type: S-1
Source: 0001193125-25-073723
Chunk: 117

Company: HCW Biologics Inc.
Filing Date: 2025-04-07
Form: S-1
Chunk 117
---
 that the transaction was in compliance with the Policy. Item 16. Exhibits. The exhibits to this registration statement are listed in the Exhibit Index to this registration statement, which immediately precedes the Signature Page, and which Exhibit Index is hereby incorporated by reference. Item 17. Undertakings. The undersigned registrant hereby undertakes:

| (1) | to file, during any period in which offers or sales are being made, a post-effective amendment to this 
 registration statement:                                                                                |

II-5

| (i) | to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the 
 “Securities Act”);                                                                                    |

| (ii) | to reflect in the prospectus any facts or events arising after the effective date of the registration statement                                                                                                                                         
 (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in    
 volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus 
 filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in         
 the effective registration statement; and                                                                                                                                                                                                               |

| (iii) | to include any material information with respect to the plan of distribution not previously disclosed in the                                                                                                                                
 registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (i), (ii) and (iii) do not apply if the registration statement is on Form                               
 S-1 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13                                
 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. |

| (2) | that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment                                                                                               
 shall be deemed to be a new registration statement